A Differential Profile of Biomarkers between Patients with Atrial Fibrillation and Healthy Controls

Ana Merino-Merino1, Ruth Saez-Maleta2, Ricardo Salgado-Aranda1,3

  • 1Cardiology Department, Hospital Universitario de Burgos, 09006 Burgos, Spain.

Insights

Biomarkers like NT-proBNP, ST2, and high-sensitivity troponin T are elevated in patients with atrial fibrillation (AF). NT-proBNP showed the highest accuracy in differentiating AF patients from healthy individuals.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Atrial fibrillation (AF) involves anatomical and electrophysiological changes in the atria.
  • Myocardial inflammation, infiltration, and dilation contribute to AF pathogenesis.
  • Several biomarkers, including NT-proBNP, Hs-Tn, and ST2, are implicated in these processes.

Purpose of the Study:

  • To investigate differences in specific cardiac biomarkers between patients with persistent non-valvular AF and healthy controls.
  • To identify which biomarkers are most effective in distinguishing AF presence.

Main Methods:

  • A cross-sectional study design was employed.
  • 115 patients with persistent non-valvular AF undergoing electrical cardioversion were included.
  • 33 healthy subjects were recruited as controls.

Main Results:

  • Significantly elevated levels of NT-proBNP, ST2, and high-sensitivity troponin T (Hs-Tn T) were observed in AF patients compared to controls (p < 0.001 for all).
  • NT-proBNP demonstrated the highest diagnostic accuracy (AUC 0.995) for differentiating AF.
  • Optimal cut-off values were identified: NT-proBNP 102 pg/mL, Hs-Tn T 11.5 ng/L, and ST2 37.7 ng/mL.

Conclusions:

  • NT-proBNP, ST2, and Hs-Tn T are significantly associated with the presence of atrial fibrillation.
  • NT-proBNP is a highly effective biomarker for AF detection.
  • These biomarkers may play a role in the onset rather than the maintenance of AF.

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
115
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
286
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
144
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
190
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21